title: Living-donor hepatectomy.
abstract: BACKGROUND
  Organ transplantation from deceased donors is still far below the need. Because of this deficiency, liver transplantations are performed mostly from live donors in many transplant centers in our country. Living-donor liver transplantation (LDLT) has evolved dramatically over the past decade. The aim of this study was to present our clinical experience with living-donor hepatectomy.
  
  
  METHODS
  We retrospectively analyzed all patients who underwent donor hepatectomy between March 2000 and September 2010. We reviewed demographic data, operation type, operation and cold ischemia times, duration of hospital stay, and postoperative complications.
  
  
  RESULTS
  During the study period, 140 living donors underwent operations for liver transplantation. We performed 108 right hepatectomies, 17 left hepatectomies, and 15 left lateral hepatectomies. The mean age of the donors was 30.8 years. There was no operative or postoperative mortality. Overall morbidity rate was 13.57% (n = 19). Nine patients had biliary leakages, 4 biliomas; 2 urinary tract infections, and 1 each inferior vena caval injury, pneumonia, portal vein thrombosis, and acute tubular necrosis. Reoperation was not required in any of these patients.
  
  
  CONCLUSIONS
  Living-donor liver transplantation is a valuable alternative for patients awaiting a cadaver organ. Live-donor hepatectomy can be performed with low morbidity. The greatest disadvantage of this procedure is the risk of the surgical operation for the individual who will experience no medical benefit from this procedure.
authors.affiliation: Department of Surgery, Ankara University School of Medicine, Ankara, Turkey.
authors.forename: G
authors.initials: G
authors.lastname: Cipe
authors.forename: A
authors.initials: A
authors.lastname: Tuzuner
authors.forename: V
authors.initials: V
authors.lastname: Genc
authors.forename: E
authors.initials: E
authors.lastname: Orozakunov
authors.forename: E
authors.initials: E
authors.lastname: Ozgencil
authors.forename: A A
authors.initials: AA
authors.lastname: Yılmaz
authors.forename: O S
authors.initials: OS
authors.lastname: Can
authors.forename: A
authors.initials: A
authors.lastname: Cakmak
authors.forename: K
authors.initials: K
authors.lastname: Karayalcin
authors.forename: S
authors.initials: S
authors.lastname: Ersoz
authors.forename: S M
authors.initials: SM
authors.lastname: Hazinedaroglu
mesh_terms: D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D006498:Hepatectomy / Q000379:methods*; D006801:Humans; D007902:Length of Stay; D016031:Liver Transplantation / Q000009:adverse effects; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012189:Retrospective Studies